Sales decline 17.78% to Rs 167.02 crore
Net loss of Panacea Biotec reported to Rs 25.49 crore in the quarter ended March 2017 as against net profit of Rs 72.15 crore during the previous quarter ended March 2016. Sales declined 17.78% to Rs 167.02 crore in the quarter ended March 2017 as against Rs 203.15 crore during the previous quarter ended March 2016.For the full year,net loss reported to Rs 86.25 crore in the year ended March 2017 as against net profit of Rs 0.87 crore during the previous year ended March 2016. Sales declined 18.06% to Rs 530.09 crore in the year ended March 2017 as against Rs 646.90 crore during the previous year ended March 2016.
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales167.02203.15 -18 530.09646.90 -18 OPM %28.6027.49 -12.9417.39 - PBDT30.5740.06 -24 19.4723.07 -16 PBT14.5223.03 -37 -46.24-48.25 4 NP-25.4972.15 PL -86.250.87 PL
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
